The footprints of cancer development: Cancer biomarkers

被引：101

作者：

Ullah, Mohd. Fahad ^{[1
]}

Aatif, Mohammad ^{[1
]}

机构：

[1] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India

来源：

CANCER TREATMENT REVIEWS | 2009年 / 35卷 / 03期

关键词：

Biomarkers; Diagnosis; Proteomics; Cancer; Microarray profile; PROSTATE-SPECIFIC ANTIGEN; MESSENGER-RNA EXPRESSION; TUMOR-SUPPRESSOR GENE; PLASMINOGEN-ACTIVATOR SYSTEM; HUMAN TISSUE KALLIKREINS; METHYLACYL-COA RACEMASE; MICRORNA EXPRESSION; PROMOTER HYPERMETHYLATION; DIFFERENTIAL EXPRESSION; CYSTEINE CATHEPSINS;

D O I：

10.1016/j.ctrv.2008.10.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Diagnostic detection and measurement of cancer disease progression are essential elements for successful cancer disease management. The early stages of cancer development carry the maximum potential for therapeutic interventions. However, these stages are often asymptomatic, leading to delayed diagnosis at the very advanced stages when effective treatments are unavailing. The application of biomarkers to cancer is leading the way because of the unique association of genomic changes in cancer cells with the disease process. They have the potential to not only help identify who will develop cancer but also to predict as to when the event is most likely to occur. In recent years, there has been an enormous effort to develop specific and sensitive biomarkers for precise and accurate screening, diagnosis, prognosis and monitoring of high risk cancer to assist with therapeutic decisions. The present article is a brief review of the emerging trends in the development of biomarkers for early detection and precise evaluation of cancer disease. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：193 / 200

页数：8

共 148 条

[1]

*AM CANC SOC, 2005, CANC STAT

[2] HETEROCHRONIC MUTANTS OF THE NEMATODE CAENORHABDITIS-ELEGANS [J].

AMBROS, V ;

HORVITZ, HR .

SCIENCE, 1984, 226 (4673) :409-416

[3] Evolving role of uPA/uPAR system in human cancers [J].

Ass, Kathleen ;

Ahmad, Aamir ;

Azmi, Asfar S. ;

Sarkar, Sarah H. ;

Sarkar, Fazlul H. .

CANCER TREATMENT REVIEWS, 2008, 34 (02) :122-136

[4] Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/ml [J].

Babaian, RJ ;

Fritsche, H ;

Ayala, A ;

Bhadkamkar, V ;

Johnston, DA ;

Naccarato, W ;

Zhang, Z .

UROLOGY, 2000, 56 (06) :1000-1006

[5] Evolutionary lines of cysteine peptidases [J].

Barrett, AJ ;

Rawlings, ND .

BIOLOGICAL CHEMISTRY, 2001, 382 (05) :727-733

[6] Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].

Belinsky, SA ;

Nikula, KJ ;

Palmisano, WA ;

Michels, R ;

Saccomanno, G ;

Gabrielson, E ;

Baylin, SB ;

Herman, JG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896

[7] Cysteine proteases as disease markers [J].

Berdowska, I .

CLINICA CHIMICA ACTA, 2004, 342 (1-2) :41-69

[8] Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].

Bhattacharjee, A ;

Richards, WG ;

Staunton, J ;

Li, C ;

Monti, S ;

Vasa, P ;

Ladd, C ;

Beheshti, J ;

Bueno, R ;

Gillette, M ;

Loda, M ;

Weber, G ;

Mark, EJ ;

Lander, ES ;

Wong, W ;

Johnson, BE ;

Golub, TR ;

Sugarbaker, DJ ;

Meyerson, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795

[9]

Borgoño CA, 2004, MOL CANCER RES, V2, P257

[10] Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer [J].

Brawer, MK ;

Cheli, CD ;

Neaman, IE ;

Goldblatt, J ;

Smith, C ;

Schwartz, MK ;

Bruzek, DJ ;

Morris, DL ;

Sokoll, LJ ;

Chan, DW ;

Yeung, KK ;

Partin, AW ;

Allard, WJ .

JOURNAL OF UROLOGY, 2000, 163 (05) :1476-1480

← 1 2 3 4 5 6 7 8 9 10 →